Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

74.66
Delayed Data
As of Jul 28
 -1.81 / -2.37%
Today’s Change
51.82
Today|||52-Week Range
77.12
+8.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line-110.0M730.0M-188.0M1.2B
 
 
 
 
 
Depreciation91.0M105.0M76.0M65.0M
 
 
 
 
 
Total Other Cash Flow1.0B-254.0M573.0M-312.0M
 
 
 
 
 
Funds From Operations940.0M691.0M63.0M713.0M
 
 
 
 
 
Funds From/For Other Operating Expenses869.0M167.0M-548.0M1.1B
 
 
 
 
 
Net Cash Flow - Operating Activities71.0M524.0M611.0M-386.0M
 
 
 
 
 
 
InvestingIncrease In Investments-651.0M-811.0M-860.0M-523.0M
 
 
 
 
 
Decrease In Investments300.0M641.0M345.0M1.8B
 
 
 
 
 
Capital Expenditures-165.0M-234.0M-285.0M-242.0M
 
 
 
 
 
Fixed Asset Disposal91.0M379.0M35.0M439.0M
 
 
 
 
 
Net Assets From Acquisitions 0.00-892.0M-219.0M-8.0M
 
 
 
 
Other Investing - Uses-855.0M855.0M0.000.00
 
 
 
Net Cash Flow Investing-1.3B-62.0M-984.0M1.4B
 
 
 
 
 
 
FinancingShort Term Borrowings427.0M-113.0M-503.0M-33.0M
 
 
 
 
 
Long Term Borrowings1.3B0.000.000.00
 
 
Long Term Debt Reduction-2.0B0.000.000.00
 
 
Net Proceeds Stock Sale27.0M30.0M35.0M71.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.00-231.0M
 
 
Common Dividends----------
Cash Dividends Paid - Total-619.0M-617.0M-618.0M-641.0M
 
 
 
 
 
Other Sources - Financing-27.0M0.000.000.00
 
 
Other Uses - Financing2.0M0.000.00-42.0M
 
 
 
Net Cash Flow - Financing-883.0M-700.0M-1.1B-792.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-3.0M14.0M-131.0M11.0M
 
 
 
 
 
 
Net Change In Cash-2.1B-238.0M-1.5B248.0M